{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-110686","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2023-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.686375+00:00","generated_at":"2026-06-16T21:48:11.356632+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"TherapeuticsMD sets combined 2022/2023 annual meeting for June 19, 2023","bullets":["Annual meeting set for June 19, 2023; record date April 20, 2023 (past).","Company did not hold a 2022 annual meeting; 2022 and 2023 meetings combined.","Deadline for Rule 14a-8 shareholder proposals is May 1, 2023.","Deadline for director nominations and universal proxy notices also May 1, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-110686","json":"https://secwatch.observer/filing/0001193125-23-110686.json","markdown":"https://secwatch.observer/filing/0001193125-23-110686.md","text":"https://secwatch.observer/filing/0001193125-23-110686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/0001193125-23-110686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312523110686/d473325d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T21:48:11.356632+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}